- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Mylan's deal to buy Perrigo is taking another potential target off the block.
The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.
With the recent deal for DAVA, Endo is now one of the best health care stocks to own.